Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

US STOCKS-S&P 500 rises on vaccine roll-out, mega-M&A activity

Published 12/15/2020, 03:18 AM
Updated 12/15/2020, 03:20 AM
US500
-
DJI
-
AMZN
-
AZN
-
ALXN
-
TSLA
-
IXIC
-
AZN
-
0700
-
SPLRCD
-
BNTX
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Alibaba sinks on Chinese regulatory ire
* Amazon leads gains in consumer discretionary
* Alexion Pharma among top boosts on AstraZeneca offer
* Indexes: Dow +0.04%, S&P 500 +0.20%, Nasdaq +0.96%

(Updates with afternoon trading)
By Karen Pierog and Noel Randewich
Dec 14 (Reuters) - The S&P 500 rose on Monday after the
launch of a nationwide COVID-19 vaccine campaign in the United
States, while Alexion Pharmaceuticals jumped on a $39 billion
buyout offer from AstraZeneca in one of the year's biggest
deals.
Administration of the vaccine developed by Pfizer PFE.N
and its German partner BioNTech BNTX.O began on Monday
following emergency-use approval from federal regulators last
week. The S&P 500 consumer discretionary index .SPLRCD led gains
among sector indexes, with Amazon AMZN.O rising 2%.
The S&P 500 gave up most of its gains after rising almost
1%. The index has surged 14% to record highs in 2020, despite
the pandemic, which has wrought economic devastation and killed
more than a million people.
"While the entire market is pleased, is optimistic, is
bullish about the arrival of the vaccine this morning into the
U.S., I think the average investor is realizing that this
roll-out, this distribution of the vaccine is not going to be a
silver bullet, is not going to go as fast as one hopes," said
Jake Dollarhide, chief executive officer of Longbow Asset
Management in Tulsa, Oklahoma.
Alexion Pharmaceuticals Inc ALXN.O was among the top
boosts to the S&P 500 .SPX and the Nasdaq .IXIC , surging
about 30% to a 4-1/2 year high after British drugmaker
AstraZeneca AZN.L AZN.O said it would buy the U.S. biotech
firm. AstraZeneca's U.S.-listed shares fell more than
7%. The Dow Jones Industrial Average .DJI was up 0.04% at
30,059.53 points, while the S&P 500 .SPX gained 0.20% to
3,670.83.
The Nasdaq Composite .IXIC added 0.96% to 12,496.99.
Uncertainty over more fiscal stimulus cut short a rally in
U.S. stocks after the Senate last week approved a one-week
extension of federal funding to avoid a government shutdown and
allow more time for negotiations on coronavirus relief and an
overarching spending bill. The focus was also on early voting in a pair of U.S. Senate
races in Georgia that will determine control of the chamber and
heavily influence lawmaking. E-commerce company Alibaba Group Holding Ltd BABA.N shed
almost 3% after China warned its internet majors of more
anti-trust scrutiny, imposed fines and announced probes into
deals involving Alibaba and Tencent Holdings Ltd 0700.HK .
Electric-car maker Tesla Inc TSLA.O rose 4% as
anticipation of its addition to the S&P 500 benchmark next week
offset a report of production delays. Walt Disney Co DIS.N fell about 2.5% after rallying on
Friday and was the biggest drag on the Dow after BMO Capital
Markets downgraded the stock.
Advancing issues outnumbered declining ones on the NYSE by a
1.05-to-1 ratio; on Nasdaq, a 1.29-to-1 ratio favored advancers.
The S&P 500 posted 25 new 52-week highs and no new lows; the
Nasdaq Composite recorded 205 new highs and 12 new lows.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.